Valens Semiconductor Reports Q1 2026 Revenue of $16.9M, Reaffirms Full-Year Guidance

Valens Semiconductor Ltd. (NYSE:VLN) reported first-quarter 2026 revenue of $16.9 million, compared with $19.4 million in the fourth quarter of 2025 and $16.8 million in the first quarter of 2025, according to an update from Stonegate Capital Partners. While the sequential decline from a stronger Q4 2025 was expected, results modestly exceeded analyst projections. Management reiterated its full-year 2026 revenue guidance of $75.0 million to $77.0 million, indicating confidence in a stronger second half.

The company reported GAAP gross margin of 62.2%, well above its guidance range of 57.0% to 59.0%. Adjusted EBITDA loss was $(5.5) million, better than the guided range of $(7.9) million to $(7.5) million. Stonegate noted that Valens continues to view 2026 as a year of measured recovery and product-cycle execution, with near-term growth building through the year as the Core Infrastructure Business (CIB) returns to sequential growth, automotive remains steady, and the A-PHY ecosystem development continues.

Management stated that broader supply-chain conditions remain an area to monitor but importantly does not see risk to meeting its full-year targets. The second half of 2026 is expected to see a meaningful acceleration, driven by CIB sequential growth, ProAV momentum, and design wins and design-ins converting into customer launches in the third and fourth quarters.

Automotive revenue grew to $5.9 million in the quarter. The VA7000 market, which addresses industrial machine vision and medical endoscopy applications, expands the addressable opportunity beyond core A-PHY automotive applications, though revenue contribution from these areas likely remains several quarters out. For more details, see the full announcement here.

For Texas, the news underscores the growing semiconductor ecosystem in the state. Valens’ focus on high-growth segments like automotive, industrial vision, and medical endoscopy aligns with Texas’ strengths in advanced manufacturing and technology. As companies like Valens invest in product cycles and design wins, the state stands to benefit from increased economic activity, job creation, and supply chain resilience. The reaffirmed guidance suggests that Valens is on track for a stronger back half of the year, which could bode well for Texas-based partners and customers in the automotive and infrastructure sectors.

Stonegate Capital Partners is a capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Its affiliate, Stonegate Capital Markets (member FINRA), offers investment banking services.